Recursion Pharmaceuticals (RXRX) experienced a price increase of 9% over the past month, positioning it against the backdrop of a broader market decline driven by geopolitical tensions and weak jobs ...

As AI gets more curious, security gaps widen. Explore the risks of prompt exfiltration and autonomous model behavior.

Given that, it's hardly encouraging that Biodexa has taken a big step forward ahead of Recursion in the development of its ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.